Evidence is presented suggesting that streptomycin binds to 16S RNA or to 30S ribosomal subunits at the same topographical site located on the RNA chain. The equally bactericidal dihydrostreptomycin binds to the same site as streptomycin but with lower affinity. The effect of drug binding to 16S RNA (measured by reconstitution inhibition) is readily reversible, while that of drug binding to 30S subunits (measured by misreading) persists after removal of the drug. Binding of the drug is not a necessary and sufficient reason for killing.
The earlier publication (1) that the site of streptomycin (Sm) binding to the 30S ribosomal subunit could be the 16S RNA may be criticized from several viewpoints. On the one hand, according to stoichiometry established for dihydrostreptomycin (H2Sm)-30S binding (2, 3) , too much Sm was bound; on the other hand, in view of the potential of nucleic acid for binding the drug, too little Sm was bound. Furthermore, it is unexpected that Sm should have any specificity at all (for example, stable binding to 16S and no binding to 23S RNA).
Experiments to answer these criticisms were designed with every attempt being made to relate binding and physiology. We report here the results of these experiments, which (1) confirm the role of 16S RNA as drug binding site; (2) demonstrate that Sm and H2Sm are quantitatively different with regard to binding (nevertheless they remain indistinguishable with respect to bactericidal action); (3) confirm that misreading is a hysteretic effect of either Sm or H2Sm and does not require the physical presence of the drug; and (4) show that binding of the drug is not a necessary and sufficient reason for killing.
MATERIALS AND METHODS
Bacterial Strains. Four Escherichia coli B strains were used. Two carry the wild-type (Sm sensitive) strA + allele; they are B wild type and Li (argF40 argRll) selected as an arginine derepressed mutant from B40, an argF amber mutant of strain B (4) . The other two are Sm resistant derivatives of L1, differing only by the strA allele which has been introduced by P1 transduction. strA40 (carried by L1-431) is a moderately restrictive allele that responds to phenotypic suppression; strAl (carried by L1-401) is a very restrictive allele, irresponsive to phenotypic suppression (5) . Four Escherichia coli K12 strains were used. One, X7029, obtained from J. Beckwith, is an F-carrying lac deletion X74. Two, A19 and Q13, are derivatives of Hfr AB301 carrying a defective RNase I (6) . Finally, A19-3 is a spontaneous Sm resistant mutant of A19.
Growth Conditions. Cultures were grown in medium L (7) [Bacto-tryptone 1%, yeast extract 0.5%, sodium chloride 0.5%, glucose 0.2%] at 370 with vigorous aeration. Cells were harvested near the end of the log phase (109 cells per ml), washed, and frozen. For the preparation of radioactive 16S RNA, 1 H2Sm from Amersham/Searle used each gave only one char spot, at the expected RF, and the only concentrated radioactivity (five to six times higher than background) on the plate corresponded to this char spot. Furthermore, the bactericidal effect (measured by a zone of inhibition on E. coli plates) was that expected for the same amount of unlabeled pure Sm and H2Sm. ent strA ribosomal mutants were exhaustively dialyzed under identical conditions. As expected from previous results (1), an excess of 14C was found in all samples containing 16S RNA, irrespective of origin (whether from strA + or strA mutated ribosomes), but an excess of 14C was found only in those samples containing 30S subunits extracted from the strA + wild-type streptomycin-sensitive (SmS) cells. This excess of 14C corresponded to 2 /Amol of Sm per umol of 16S RNA, and about 2.7 per umol of 30S subunits. Surprisingly, however, H2Sm (as determined by measuring excess 3H) did not bind to any sample of either 30S subunits or 16S RNA in any meaningful amount (less than 0.01 mol of drug per mol of ribosomal material).
These results were interpreted to be a consequence of reduced affinity of H2Sm for the drug-binding site(s), so that the H2Sm complexes, in contrast to the Sm complexes, were unable to withstand the drastic conditions of exhaustive dialysis. Accordingly, an equilibrium dialysis experiment was performed in which H2Sm binding to ribosomal material was determined in the presence of free H2Sm. The drug was allowed to diffuse into a dialysis bag containing 30S subunits or 16S RNA from different ribosomal mutants, experimental conditions being such that when equilibrium was reached, the concentration of ribosomal material relative to that of free H2Sm was 100 to 1. The surplus 3H per unit volume found inside the bag is an index of the affinity for H2Sm of the ribosomal material tested. The results, presented in Table 1 , show that the expected drug-binding pattern for H2Sm is observed under equilibrium dialysis conditions. The strA + 30S subunits bound the most drug, in quantitative agreement with results reported by others (11) . In contrast, no binding by Reconstitutions were performed by mixing stoichiometric amountst of 30S protein with pre-watmed 16S RNA (both in RC+ buffer)
in the presence or absence of drug (usually each sample contained 1-3 mg of 16S RNA). The drug was added either directly to the 16S RNA during pre-warming at a niolar ratio of 10: 1, drug to RNA, or before exhaustive dialysis at an initial molar ratio of 100: 1, drug to RNA. Two controls (without drug), one dialyzed as in exhaustive dialysis, and a second un-dialyzed, gave essentially identical results, and their average value is therefore reported here. At the conclusion of the reconstitution incubation, the mixture was immediately cooled and centrifuged. The pellet obtained by this procedure (when the reconstitution is successful, 1.5-4 mg of 30S subunit are recovered) was dissolved in N + buffer, its concentration was adjusted to 2.5 mg/ml, and incorporation of phenylalanine directed by poly-(uridyiic acid) was measured in an aliquot of this solution. The amount of 50S subunit for each incorporation was 50 ,ug from a standard preparation of L1 ribosomes. This is the stoichiometric amount needed for 25 Isg of reconstituted 30 S, which is the maximum obtainable from our experiment. The values in the table should therefore be interpreted as a titration measurement of the amount of 30S present under each condition. (Note that reconstitutions performed with heterologous components give a low yield of 30S subunit, as expected.) * Li 168 RNA was 3H labeled in order to facilitate interpretation of analytical sucrose gradients which were performed upon the pelleted material recovered from each attempted reconstitution. When biological activity was recovered from a reconstitution attempt, gradient analysis showed 30S material to be present; when biological activity was absent, analysis showed 16S RNA to be present, no evidence for hydrolysis being seen. those 30S subunits formed from strA + proteins had an associated radioactivity, corresponding to 0.6-0.7 Sm:30S RNA. The remaining radioactivity in each case was found at the top of the gradient.
Drug binding to 30S subunits might be studied independently from direct measurement of bound radioactivity if one takes advantage of the misreading effect of Sm and H2Sm on amino-acid incorporation directed by synthetic messenger. For such an experiment 30S subunits from strA+, strA40 or strAl strains (LI, L1431, and L1401, respectively) are exposed to Sm or H2Sm and subsequently dialyzed exhaustively. Their ability to induce isoleucine misreading in a poly(U)-directed phenylalanine incorporating system is then determined, without or with further addition of drug to the incorporation mix. Table 4 gives the results of four different experiments performed with strA+ 30S subunits exposed to four different concentrations of the two drugs, strA40 and strAl subunits also being tested. It is found, as expected, that either drug induces the same level of misreading when added to strA+ 30S subunits during incorporation, and that misreading is practically zero with strAl subunits and barely measurable with strA40. It was also expected, and it is found, that misreading is maximal with 30S subunits exposed to Sm prior to exhaustive dialysis, since the Sm-30S subunit complex In each experiment (horizontal lines), 1 ml of .30S subunit solution of about 3 mg/ml was subjected to exhaustive dialysis against RC+ buffer in the presence or absence of either Sm or H2Sm at the molar ratios shown in the table. At the conclusion of exhaustive dialysis, the 30S subunit concentration was adjusted to 2.5 mg/ml, and in vitro poly(uridylic acid)-directed incorporation of phenylalanine and isoleucine wars measured. The numbers in the table are, therefore, a direct index of misreading, since the amiount of 30S siubunit (25 ug) in each incorporation was kept constant, and limiting.
* A control without dialysis was also performed and the value reported here is the average of the two essentially identical numbers.
t In order to measure the maximum misreading index obtainable, 2 lsg pf either Sm or H2Sm were added per incorporation to all samples, whether or not exhaustive dialysis was performed (in the case of the controls) and whether Sm or H2Sm was present during exhaustive dialysis. The misreading index obtained from each of these four conditions was so similar that the average value is reported here. stably to 30S subunit one could expect no effect on misreading by H2Sm followed by exhaustive dialysis. However, it is seen in the table that misreading is high also with the 30S subunit exposed to H2Sm (about 70% of that with Sm-30S subunit). This result suggests that contact with the drug produces an alteration in the 30S subunits which persists even after the drug has been removed, in agreement with published in vivo observations (12) (13) (14) (1974) and H2Sm in a test independent from the use of labeled drugs. We had already shown (1) that Sm prevented 16S RNA and 30S proteins from E. coli B from reconstituting active 30S particles, and that this inhibition persisted even after exhaustive dialysis of the 16S RNA-Sm complex. We find now that H2Sm has an identical effect when added directly to the reconstitution mixture, but that its inhibition is completely lost after exhaustive dialysis, a result consistent with the observed binding difference between Sm and H2Sm. The inhibitory effect of Sm upon reconstitution is only observed using B strains, and it is not seen when 30S components of strain K12 are used. Moreover, by criss-cross reconstitution experiments, it is shown that the inhibitory effect depends upon the protein source, and not on the 16S RNA source. If the 16S RNA-Sm binding were an artifact, blocking specifically the 16S RNA assembly sites, then an interference with assembly should be expected with the proteins of either strain, since in the absence of the drug they can easily produce an interstrain hybrid 30S particle.
If the ['4C]Sm-16S RNA complex is incubated with K12 proteins from either a strA+ (SmS) or a strA mutated (SmR) strain, active 30S subunits are obtained in both cases, but only those from the strA + strain bear attached 14C radioactivity. This result is consistent with the notion that the 16S RNA drug-binding site could not be an assembly site, since it must be open in the completed 30S particle to enable the sensitive ribosomes to bind Sm; and that the drug site in the naked 16S RNA is topographically the same as in the 16 S associated with the proteins to form the 30S subunit. Unfortunately, this experiment does not exclude the possibility that the Sm is dislodged from the 16S RNA in both cases by either strA + or strA-mutated proteins, a 30S particle is formed, and Sm rebound to the newly-formed strA + 30S particle; therefore, it should be considered circumstantial evidence at best.
Melting and re-annealing of 168 RNA largely affects the number of [14C]Sm molecules bound (1), and we now find the binding of [PH] H2Sm in equilibrium dialysis to be dependent upon the buffer composition. The dependence of drug binding upon salt concentration has also been observed by others (15 The rigidity conferred upon the 16S RNA chain when embedded into the 30S structure might account for a drastic difference between 16S RNA and 30S subunits with respect to the effects of drug binding. Dialysis easily removes dHSm from either 16S RNA or 30S subunits, with the effect on 16S RNA being readily reversed (reconstitution inhibition is completely relieved after exhaustive dialysis), while those effects on the 30S subunit persist after removal of the drug ([3H]H2Sm is not detectable, yet the ribosomes still misread as if they were in the presence of the drug). A similar persistence of drug effects has also been observed in vivo in two instances: (a) pregrowth in the presence of Sm, H2Sm, or paromomycin confers on a strA4O strain the ability to suppress phage nonsense mutations by ambiguity, although the drug is no longer present at the moment of infection (12) ; and (b) as "phenotypic masking" in drug dependent strains that require either Sm or paromomycin for growth but are sensitive to these drugs used together or to either one after previous growth in the other (13, 14) . In both cases, extracted ribosomes are shown: (1) to misread, although free of the drug (which was added during pregrowth); and (2) to be restored to normal accuracy by high salt treatment. This suggests a reversible structural modification of the ribosome brought about by the drug and persisting after its removal.
Finally 
